Caris molecular profiling performs thorough molecular testing on DNA, RNA and proteins to identify the biomarkers driving a patient’s tumor, and to compare the biomarkers with data from clinical studies around the world. Here’s how the process works:
The ordering clinician collects and sends a tissue sample to Caris
Comprehensive testing on DNA, RNA and proteins is performed at our state-of-the-art, 66,000 sq. ft. laboratory
Team interprets the data using thousands of relevant clinical papers to match your tumor’s biomarkers to treatment options
Results are returned in approximately 10-14 days in an online and easy-to-understand format
Profiling reveals the molecular blueprint to help guide precise treatment decisions
The Caris Molecular Profiling Report delivers high impact results, including potentially relevant, actionable clinical information, in an easy-to-interpret format. Every report includes access to the MI Portal and the Clinical Trials Connector™, which matches each patient’s unique biomarker expression profile to open, pertinent, clinical trial opportunities.
AI bioinformatics and machine learning capabilities.
Place an order today for a comprehensive, personalized Caris report.